Stopped in its tracks

Sufferers of rheumatoid arthritis have been given hope of a new drug that may stop the condition. RoActemra, administered monthly through injections, has been indicated by trial data to work alongside an existing treatment, methotrexate, to stop the condition in which the body begins attacking its own joints. However, the combination of the two drugs, the former of which will be manufactured by Roche, does nothing to reverse the effects of the condition. The treatment was trialled using 1,190 patients. In those taking both medications, rheumatoid arthritis was halted in just under half ...